Hemoglobinosis C occurs mainly in Africa and America with a high
frequency in West Africa. In Senegal, homozygous hemoglobinopathy CC
constitutes a very rare profile of which only 3 cases are followed in the
clinical hematology department of Dakar. The 1stcase is a 49-year-old
female patient, with notion of 1st degree consanguinity, and a long
history of abdominal pain who presented a poorly tolerated anemic syndrome and
splenomegaly. The biological assessment showed moderate anemia (7.6 g/dL) with
microcytic hypochromia and a CC profile (HbC = 99.2%; HbA2 = 0.8%) on
hemoglobin electrophoresis. The second case was a 22-year-old female patient
with a notion of 2nd degree consanguinity who presented a Chauffard
triad. The haemogram showed mild anaemia (11g/dL), microcytic and hypochromic. Hemoglobin
electrophoresis confirmed a CC profile (HbC = 95.3%; HbA2 = 4.7%). The third
patient was 27 years old, with a history of diffuse abdominal pain and 2nddegree consanguinity. The
haemogram and haemoglobin electrophoresis confirmed the CC profile (HbC = 94.6%;
HbA2 = 5.4%). The negativity of the Emmel test in front of this presentation
suggestive of sickle cell disease means that this type of hemoglobinopathy is
diagnosed late in our regions. We therefore recommend the systematic performance
of hemoglobin electrophoresis in the presence of any chronic hemolytic anemia.
References
[1]
Bookchin, R.M., Nagel, R.L., Ranney, H.M. and Jacobs, A.S. (1966) Hemoglobin CHarlem: A Sickling Variant Containing Amino Acid Substitutions in Two Residues of the β-Polypeptide Chain. Biochemical and Biophysical Research Communications, 23, 122-127. https://doi.org/10.1016/0006-291X(66)90515-8
[2]
Goossens, M., Garel, M.C., Auvinet, J., Basset, O., Ferreira Gomes, P., Rosa, J., et al. (1975) Hemoglobin C Ziguinchor : The Second Sickling Variant with Amino Acid Substitutions in 2 Residues of the β Polypeptide Chain. FEBS Letters, 58, 149-154. https://doi.org/10.1016/0014-5793(75)80246-8
[3]
Ahmed, S.G. and Ibrahim, U.A. (2021) Non-S Sickling Hemoglobin Variants: Historical, Genetic, Diagnostic, and Clinical Perspectives. Oman Medical Journal, 36, e261. https://doi.org/10.5001/omj.2021.102
[4]
Bain, B.J. (2015) Hemoglobin C Disease. American Journal of Hematology, 90, 174. https://doi.org/10.1002/ajh.23915
[5]
Diop, S., Diop, D., Seck, M., Guèye, Y., Faye, A., Dièye, T.N., et al. (2010) Predictive Factors of Chronic Complications in Adult Sickle Cell Anemia Patients in Dakar, Senegal. Medecine Tropicale (Mars), 70, 471-474.
[6]
Seck, M., Faye, B.F., Sall, A., Fall, A., Touré, S.A., Dieng, N., et al. (2017) Profil Course of SC Sickle-Cell Patients in Dakar: A Case-Control Study with SS Sickle Cell Form. Mali Medical, 32, 7-12.
[7]
Padaro, E., Kueviakoe, I.M.D., Layibo, Y., Magnang, H., Mawussi, K. and Segbena, A.Y. (2018) Hémolyse au cours de l’hémoglobinose homozygote CC : Etude d’une cohorte de 90 patients colligés au CHU campus de Lomé (Togo). Revue Africaine de Médecine Interne, 5, 25-31.
[8]
Ouzzif, Z., El Maataoui, A., Oukhedda, N., Messaoudi, N., Mikdam, M., Abdellatifi, M., et al. (2017) Hemoglobinosis C in Morocco: A Report of 111 Cas. Tunisie Medicale, 95, 229-233.
[9]
Travassos, M.A., Coulibaly, D., Laurens, M.B., Dembélé, A., Tolo, Y., Koné, A.K., et al. (2015) Hemoglobin C Trait Provides Protection from Clinical Falciparum Malaria in Malian Children. The Journal of Infectious Diseases, 212, 1778-1786. https://doi.org/10.1093/infdis/jiv308